• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Perfusion imaging may be useful for selecting stroke patients for thrombolysis

byDylan WolmanandAaron Maxwell, MD
September 25, 2014
in Imaging and Intervention, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. When used for the selection of patients with stroke for intravenous thrombolysis within 3 hours of symptom onset, computed tomography perfusion imaging (CTP) appears to provide comparable outcomes relative to the use of other imaging modalities.

2. Outcomes trended toward superiority among patients selected for intravenous thrombolytic treatment beyond 3 hours of symptom onset on the basis of CTP, relative to the earlier treatment group.

Evidence Rating Level: 2 (Good)

Study Rundown: In suspected cases of acute stroke, imaging by non-contrast head CT is considered the standard of care due to its widespread availability, rapid scan time, and high sensitivity for intracranial hemorrhage. However, unlike magnetic resonance imaging or CTP techniques, static non-contrast CT imaging does not provide information about the area of at-risk brain tissue secondary to reduced cerebral blood flow. The current study systematically reviewed the use of CTP in acute stroke to determine its safety and efficacy in selecting patients for thrombolytic therapy, as CTP could be useful in identifying a larger patient base that may benefit from treatment than static imaging alone. A meta-analysis was performed using all recent CTP literature with regard to stroke therapy, regardless of study type, in order to determine baseline complication rate, represented by in-hospital intracerebral hemorrhage (ICH) and 90-day all-cause mortality, and patient recovery status, as assessed by a modified Rankin Scale score at 90 days. The results suggest that the decision to pursue thrombolytic therapy based on CTP is comparable to the standard of care with regard to rates of ICH, mortality, and functional recovery, and that CTP may help select patients beyond 3 hours of symptom onset that could benefit from therapy. The study results are limited by the inclusion of heterogeneous, small, uncontrolled or non-randomized trials, which may have introduced bias. Additionally, inconsistent reporting of ages and NIHSS scores among included studies prevented subgroup analysis based on age and severity of symptoms at presentation. These limitations underscore the need for further trials to elucidate the value of CTP in therapeutic guidance for acute stroke.

Click to read the study in Radiology

Relevant Reading: Mismatch-based delayed thrombolysis: a meta-analysis

In-Depth [meta-analysis]: A meta-analysis of 13 articles was performed, including randomized controlled trials, as well as prospective and retrospective cohort trials. All studies examined the use of CTP in a selection of patients for thrombolysis without an alternative imaging modality for comparison. Patient ages were consistent across most trials, with mean ages ranging from 58-73 years. Baseline NIHSS scores at presentation were not collected for all trials. Results were stratified into groups treated within or after 3 hours of symptom onset. All-cause mortality at 90 days, ICH rates, and favorable outcome rates (as reported by a 90-day modified Rankin Scale score < 2) were consistent with outcomes for patients treated within 3 hours based on other imaging modalities, at 12.5%, 3.3% and 42.5%, respectively. With treatment beyond 3 hours of symptom onset, outcomes paradoxically trended toward improvement but did not significantly differ at 2.9%, 3.9% and 69.9%, respectively.

RELATED REPORTS

Bivalirudin during and post-percutaneous coronary intervention reduces bleeding and mortality compared to heparin monotherapy

The Scan by 2 Minute Medicine®: the New Cost of Insulin, Beyond IVF, the Spotlight on RSV and Influenza, and Theranos Founder Sentenced to 11 Years!

#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

More from this author: Intravenous contrast may not increase risk of acute kidney injury, Improved diagnosis of incidental adrenal masses by dual-energy CT 

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

 

Tags: computed tomographystrokethrombolysis
Previous Post

Comparison of treatment options for varicose veins [CLASS trial]

Next Post

Admission may not be needed following sleep apnea surgery

RelatedReports

Appropriate use criteria for angiography may frequently miss obstructive coronary artery disease
Cardiology

Bivalirudin during and post-percutaneous coronary intervention reduces bleeding and mortality compared to heparin monotherapy

December 6, 2022
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: the New Cost of Insulin, Beyond IVF, the Spotlight on RSV and Influenza, and Theranos Founder Sentenced to 11 Years!

November 30, 2022
#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
StudyGraphics

#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

November 24, 2022
Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Personalized cooler dialysate does not reduce cardiovascular events for hemodialysis patients

November 23, 2022
Next Post
Admission may not be needed following sleep apnea surgery

Admission may not be needed following sleep apnea surgery

Preterm birth associated with elevated plasma insulin levels

Long working hours linked with diabetes in low socioeconomic groups

Androgen deprivation in prostate cancer: intermittent may compromise survival

Adjuvant radiotherapy may improve survival in node-positive prostate cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options